Updates are available Correction dated 2022-04-22
Click to view Correction: https://doi.org/10.1007/s11064-022-03602-3
-
Authors
Klugmann, Matthias
Kalotay, Elizabeth
Delerue, Fabien
Ittner, Lars M.
Bongers, Andre
Yu, Josephine
Morris, Margaret J.
Housley, Gary D.
Fröhlich, Dominik https://orcid.org/0000-0002-9551-3620
-
Funding
Funding for this research was provided by:
Medical Research Future Fund (MRFF-ARLKO)
European Leukodystrophy Association (ELA 2018-014I2)
Mission Massimo Foundation (Mission Massimo Foundation)
University of New South Wales
- License Information
-
More Information
Article History
Received: 5 October 2021
Revised: 5 October 2021
Accepted: 15 March 2022
First Online: 31 March 2022
Change Date: 22 April 2022
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s11064-022-03602-3
Declarations
:
: MK is an employee of Boehringer Ingelheim Pharma GmbH & Co. KG. The authors declare that they have no competing interests.
